Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Healthmed Services Ltd. (OTC: HEME).

Full DD Report for HEME

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-120.00210.00120.00250.0012655,420
2018-12-11N/A0.0025N/AN/A0
2018-12-100.00220.00250.00250.0017229,195
2018-12-07N/A0.0027N/AN/A0
2018-12-060.00210.00270.00290.0017110,920

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1250,000655,4207.6287Cover
2018-12-1035,000229,19515.2708Cover
2018-12-0650,000110,92045.0775Short
2018-12-0440,420641,2606.3032Cover
2018-12-03468,800817,32057.3582Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on HEME.


About Healthmed Services Ltd. (OTC: HEME)

Logo for Healthmed Services Ltd. (OTC: HEME)

The Company has acquired the rights from Dr. Henry J. Smith to an improved Donor Organ Transport System Patent Pending . By reconditioning the donor organ such as the heart, kidney or liver and extending the period of time for transport, it will be possible to improve the success rates of transplants. Also, by having a device that can maintain the organ for an extended period in vitro, it will be possible to test drugs on isolated organs in vitro before starting clinical trials on patients. The Company has made significant progress in its research program and has a working model of a portable organ transport device. Initial research studies have been completed showing that isolated donor organs could be kept alive for an extended period of time using the organ transport system developed. It represents strong possibilities to be the foundation for an enterprise highly profitable to the Company and its shareholders. lt br / gt A merger has been filed with Diabetes Reference Services Inc. to absorb thier proprietary technology into the Company. Its business model is to distribute diabetes test kits through retail outlets and online, enabling consumers in a totally confidential manner to predict their propensity to contract diabetes based on testing their saliva to detect certain significant proteins that may be present. Results are available online only to purchasers though confidential codes provided in their kits, without revealing any users identities to anyone but the purchaser.

 

Contact Information

 

 

Current Management

  • Henry A. Smith / President, Secretary
  • Richard Floegel / VP, Admin.
  • Richard Floegel /
  • Henry A. Smith /

Current Share Structure

  • Market Cap: $386,861 - 03/16/2018
  • Authorized: 1,000,000,000 - 05/13/2011
  • Issue and Outstanding: 967,153,003 - 06/06/2011
  • Float: 612,299,014 - 06/20/2011

 



Daily Technical Chart for (OTC: HEME)

Daily Technical Chart for (OTC: HEME)


Stay tuned for daily updates and more on (OTC: HEME)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: HEME)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in HEME is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of HEME and does not buy, sell, or trade any shares of HEME. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/